You are here: Industry Insights > DSRU

News List

DSRU says more research needed to understand immunocompromised patients' responses to COVID-19 vaccines pharmatimes
July 19, 2021
The UK’s independent Drug Safety Research Unit (DSRU) has called for more research to understand the weaker COVID-19 vaccine protection for immunocompromised patients.
Global Pharmacovigilance Observatory to aid pharma’s understanding of regulatory decisions europeanpharmaceuticalreview
April 09, 2021
The observatory will collate drug safety data, analyses and decisions into a single source to help pharma identify regional differences in decision-making.
New research project aims to improve understanding of differing decisions on medicine use pharmatimes
March 30, 2021
A new research project, announced by the UK’s Drug Safety Research Unit (DSRU), will aim to improve understanding of differing decisions on medicine use between different countries and regions.
DSRU plans ‘post-authorisation’ study of COVID-19 vaccines in the UK pharmatimes
December 04, 2020
The Drug Safety Research Unit – an independent academic unit based in Southampton, UK – is planning to conduct an active surveillance study on COVID-19 vaccine following regulatory authorisation.
Drug Safety Research Unit says repurposed drugs for COVID-19 still require a lot of testing europeanpharmaceuticalreview
November 19, 2020
The DSRU said that global collaboration would be required to successfully expedite the necessary safety and efficacy evaluations for repurposed drugs to be used in COVID-19 patients.
New consortium will monitor safety/efficacy of COVID-19 vaccines pharmatimes
June 30, 2020
A new consortium has been established by the Drug Safety Research Unit (DSRU) in Southampton and the Medicines Monitoring Unit (MEMO Research) at the University of Dundee to monitor the safety and effectiveness of COVID-19 vaccines.
Consortium established to monitor COVID-19 vaccines after marketing europeanpharmaceuticalreview
June 28, 2020
A new consortium has been formed for the study of COVID-19 vaccines after their approval, to monitor their safety and efficacy.
UK researchers form consortium to monitor Covid-19 vaccines pharmaceutical-technology
June 24, 2020
The University of Dundee’s Medicines Monitoring Unity (MEMO Research) and the Drug Safety Research Unit (DSRU) in the UK have formed a consortium to track the safety and effectiveness of Covid-19 vaccines.